GlassScriptPhysician profile
Deborah Ann Hendryx
NPI 1528373966
$1,499.00
in general payments reported to CMS, 2019-2025
26 companies · $92.96 in 2025
The $92.96 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $189 · 2021: $199 · 2022: $232 · 2023: $254 · 2024: $315 · 2025: $92.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $253.92 | 2019-2023 | |
| Hologic Sales and Service, LLC | $176.66 | 2019-2025 | Fluent Fluid Management System, Novasure, Myosure Tissue Removal Device |
| Medical Device Business Services, INC. | $117.16 | 2024 | Stratafix |
| Pfizer INC. | $108.60 | 2019-2023 | |
| Myovant Sciences INC. | $105.55 | 2022 | |
| Coopersurgical, INC. | $93.41 | 2019-2024 | Paragard T 380a, Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Bayer Healthcare Pharmaceuticals INC. | $83.43 | 2019-2023 | |
| Astellas Pharma US INC | $76.98 | 2022-2024 | Myrbetriq, Veozah |
| Sage Therapeutics, LLC | $74.48 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $67.21 | 2020-2024 | Slynd |
| Mayne Pharma Commercial LLC | $48.82 | 2022 | |
| Organon LLC | $38.66 | 2021-2024 | |
| Millicent US INC | $37.00 | 2023-2025 | Intrarosa, Femring |
| Sumitomo Pharma America, INC. | $25.55 | 2023 | Myfembree |
| Evofem Biosciences, INC. | $21.63 | 2023 | Phexxi |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $20.66 | 2024 | Ova1 |
| Monaghan Medical Corporation | $20.02 | 2024 | Aerochamber |
| Dexcom, INC. | $18.07 | 2025 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $16.98 | 2022 | |
| Covidien LP | $16.23 | 2019 | |
| Northgate Technologies, INC. | $14.98 | 2024 | Stimsite |
| Avion Pharmaceuticals | $14.44 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.99 | 2020 | |
| Lupin INC. | $12.25 | 2019 | |
| Duchesnay USA Incorporated | $11.82 | 2019 | |
| Therapeuticsmd, INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Hendryx listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.